Inovio Pharmaceuticals INO
NASDAQ INO
$1.48 +0.02 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Inovio Pharmaceuticals (INO) Total Debt (2009 - 2023)

Updated

Inovio Pharmaceuticals' Total Debt was $16.77 million in Q4 2023, up 1.7% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Total Debt (2009 - 2023) Analysis & Trends

From Q1 2019 onward, Inovio Pharmaceuticals has reported Total Debt for 6 quarters.

  • The Q4 2023 figure marks the highest quarterly Total Debt since Q2 2019.
  • Per Business Quant data, INO's Total Debt in the three quarters before Q4 2023 was $16.49 million (Q3 2023), $16.71 million (Q2 2023) and $16.39 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Inovio Pharmaceuticals 143.02 Mn -38.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 16.77 Mn
Sep 30, 2023 16.49 Mn
Jun 30, 2023 16.71 Mn
Mar 31, 2023 16.39 Mn
Jun 30, 2019 62.76 Mn
Mar 31, 2019 60.56 Mn
Jun 30, 2010 1.01 Mn
Mar 31, 2010 12.10 Mn
Dec 31, 2009 12.11 Mn
Sep 30, 2009 12.11 Mn
Jun 30, 2009 16.49 Mn
Mar 31, 2009 12.07 Mn
API Access

Inovio Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=INO&period=max&api_key=YOUR_API_KEY